GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DERM · Sep 30, 2024

Journey Medical Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001410578-24-001877General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

135.25% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generation50thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-7.91% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-4.25% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure63thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

80.58% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.gross_margin

63.87% · CORE · VALID

Operating margin63thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

-19.78% · CORE · VALID

R&D intensity0thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

5.76% · OPTIONAL · VALID

SBC intensity88thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

11.21% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History16 statesHistory building
Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20246/8 normalizedLevel 3Dec 31, 20247/9 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
132.94%
Current
135.25%
Delta
2.31%
Cash Generation Increased
Previous
-34.84%
Current
-7.91%
Delta
26.93%
Growth Increased
Previous
-12.42%
Current
-4.25%
Delta
8.16%
Inventory Pressure Increased
Previous
65.21%
Current
80.58%
Delta
15.37%
Margin Increased
Previous
55.97%
Current
63.87%
Delta
7.91%
Profitability Decreased
Previous
-19.70%
Current
-19.78%
Delta
-0.08%
R And D Intensity Decreased
Previous
6.15%
Current
5.76%
Delta
-0.39%
Sbc Intensity Decreased
Previous
11.27%
Current
11.21%
Delta
-0.06%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · DERM Fundamental State →Transitioned To · DERM Fundamental State →Transitioned To · DERM BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · DERM CASH_GENERATION_INCREASED →Transitioned To · DERM GROWTH_INCREASED →Transitioned To · DERM INVENTORY_PRESSURE_INCREASED →Transitioned To · DERM MARGIN_INCREASED →Transitioned To · DERM PROFITABILITY_DECREASED →Transitioned To · DERM R_AND_D_INTENSITY_DECREASED →Transitioned To · DERM SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.